Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | X025908 | — |
No additional AE details reported.; was inadvertently administered expired VAQTA on 04/25/2025; This spontaneous report was received from a medical assistant and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 25-APR-2025, the patient was inadvertently administered dose of expired hepatitis A vaccine, inactivated (VAQTA) (0.5 ml/dose; lot # X025908, expiration date: 24-APR-2025; strength, formulation, dose #, route and anatomical site were unknown) for prophylaxis (expired product administered). No additional adverse event details reported (no adverse event). The outcome of the event was unknown.